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Abstract
Background: For older adults without diabetes, cognitive functioning has been implicated as a
predictor of death and functional disability for older adults and those with mild to severe cognitive
impairment. However, little is known about the relationship between cognition functioning on
mortality and the development of functional disability in late life for persons with diabetes. We
examined the relative contribution of cognitive functioning to mortality and functional disability
over a 2-year period in a sample of nationally representative older US adults with diabetes who
were free from cognitive impairment through secondary data analyses of the Second Longitudinal
Study of Aging (LSOA II).
Methods: Participants included 559 US adults (232 males and 327 females) ≥ 70 years old who had
diabetes and who were free from cognitive impairment were examined using an adapted Telephone
Interview of Cognitive Status (TICS), Activities of Daily Living (ADL), and Instrumental Activities of
Daily Living (IADL).
Results:  Multivariate logistic regression was conducted to investigate the independent
contribution of cognitive functioning to three mutually exclusive outcomes of death and two
measures of functional disability status. The covariates included in the model were participants' sex,
age, race, marital status, educational level, duration of diabetes, cardiovascular disease (CVD)
status, and self-rated health. Persons with diabetes who had the lowest levels of cognitive
functioning relative to the highest level of cognitive functioning had a greater odds of dying (AOR
= 0.80, 95% CI = 0.67–0.96) or becoming disabled (AOR = 0.87, 95% CI = 0.78–0.97) compared
to those people who were disability free.
Conclusion: Older adults with diabetes and low normal levels of cognition, yet within normal
ranges, were approximately 20% more likely to die and 13% more likely to become disabled than
those with higher levels of cognitive functioning over a 2-year period. Brief screening measures of
cognitive functioning could be used to identify older adults with diabetes who are at increased risk
for mortality and functional disability, as well as those who may benefit from interventions to
prevent or minimize further disablement and declines in cognitive functioning.
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Background
Cognitive dysfunction appears to be an additional com-
plication of diabetes [1]. Accelerated declines in cognitive
functioning have been consistently reported for older and
middle-aged adults with diabetes [1-9]. In a recent system-
atic analysis, Cukierman and colleagues concluded that
people with diabetes had a 1.2 to 1.5-fold greater change
over time in measures of cognitive functioning and that
the odds of future dementia was increased 1.6-fold[1]. In
addition, the risk of cognitive decline was greater for those
who had diabetes longer [4,5] and for those not treating
their diabetes [4].
Older adults with diabetes have a heavy burden of disabil-
ity and functional disability [8,10-14]. About 20–50% of
people with diabetes report having a disability, which is
2–3 times more likely than the general population [13].
One-third of people with diabetes have difficulties with at
least one activity of daily living (ADL, includes bathing,
dressing, etc). In addition, diabetes is shown to be related
to IADL limitations [15] as 57% have at least one limita-
tion in instrumental activities of daily living (IADL,
includes shopping, preparing meals, etc) [12].
Cognitive impairment and functional disability have sim-
ilar trajectories associated age and are important public
health issues of an aging population [15]. For older adults
without diabetes, cognitive functioning has been impli-
cated as a predictor of functional disability for older
adults [3,15-21] and those with mild to severe cognitive
impairment [22,23]. Diabetes is a common chronic con-
dition in older adults that afflicts a large proportion of the
aging population as approximately 10.3 million or 20.9%
of adults aged ≥ 60 years old had diabetes in 2005 [24]
and the diabetes prevalence rates for older adults have
been increasing steadily since the 1980s [25]. However,
little is known about the relationship between cognition
functioning and the development of functional disability
and mortality in late life for persons with diabetes. We
examined the relative contribution of cognitive function-
ing to mortality and functional disability over a 2-year
period in a sample of nationally representative older US
adults with diabetes who were free from cognitive impair-
ment through secondary data analyses of the Second Lon-
gitudinal Study of Aging (LSOA II) [26].
Methods
Participants
Data for the present investigation came from the LSOA II,
a publicly available data set, which consists of a nationally
representative sample with a multistage complex sam-
pling design. The baseline of LSOA II was the 1994
National Health Interview Survey, Second Supplement on
Aging II (SOA II), conducted by the Centers for Disease
Control and Prevention after ethical approval for the
study was obtained by the National Center for Health Sta-
tistics' Research Ethics Review Board. Participation in the
survey was voluntary and confidentiality of respondents
and their responses was assured by adherence to Section
308(d) of the Public Health Service Act (42 USC 242 m).
In addition to receiving an advance letter describing the
study prior to the interview, the interviewer described the
voluntary nature of the study, participants' right to with-
drawal at anytime, and the confidentiality measures
employed. Informed consent then was obtained verbally
from the participant when they gave their permission to
proceed with the interview.
The SOA II was comprised of 9,447 community-dwelling,
civilian men and women who were at least 70 years old
(mean = 77.3, SE = .20). The follow-ups were conducted
primarily using a Computer-Assisted Telephone Interview
system. The data in the first follow-up, were collected
between May 1997 and May 1998, while the second fol-
low-up was obtained between June 1999 and August
2000. Cognitive measures were collected for the first time
during the first follow-up; therefore, we limited our anal-
yses to 559 individuals with diabetes who completed cog-
nitive measures without proxy.
Materials
Cognitive functioning was assessed at both follow-ups
using an adapted telephone interview for cognitive status
(TICS) [27]. Cognitive functioning assessed two inde-
pendent factors of cognition: mental status (orientation,
registration, and attention) and memory (immediate ver-
bal memory). Participants' scores on the mental status
items (0–10 points; e.g., Who is the president and vice-
president?; What is used to cut paper?; What is a desert
plant?; What is the day/date/month/year?; counting back-
wards from 20 and from 86) and memory task (0–10
points; 10 item list of concrete nouns) were summed
resulting in a cognitive functioning score ranging from 0
to 20, with higher scores indicating higher levels of cogni-
tive functioning. Methodologically, assessing cognitive
functioning via the telephone is a reliable and valid
approach [28-31]. Participants whose cognitive score was
at least 1.5 standard deviation units below the mean per-
formance were considered to have mild to severe cogni-
tive impairment and were excluded from the analyses
[32,33].
Diabetes was assessed by self-report, which is considered
a reliable and valid indicator diabetes status [10,12,15,34-
36]. Participants indicated whether they had diabetes at
baseline and if they now have diabetes at first and second
follow-ups. We considered people to have diabetes if they
indicated "yes" to the diabetes questions.BMC Geriatrics 2006, 6:8 http://www.biomedcentral.com/1471-2318/6/8
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Functional disability status was measured using self-
reported ADLs and IADLs during the first and second fol-
low-ups. ADLs, which are comprised of basic self-care
tasks necessary for an adult to live independently, include
bathing, dressing, eating, transferring, walking, and toilet-
ing, were assessed in the LSOA II. IADLs are higher-
ordered skills that are also necessary for independent liv-
ing. The IADL tasks assessed on the LSOA II were prepar-
ing meals, grocery shopping, managing money, using the
telephone, doing light/heavy housework, and managing
medications. Participants were classified into one of three
mutually exclusive categories, death and two categories of
functional disability status by their self-reported ability in
the second follow-up to perform ADL and IADL tasks: 1).
deceased – died between first and second follow-up as
indicated by interviews with surviving family and friends;
2). ADL and/or IADL disabled – unable to perform at least
one ADL task and/or at least one IADL task; and 3). disa-
bility free – able to perform all ADL and IADL activities. In
addition, we controlled for participants functional disa-
bility status at the first follow-up.
Covariates modeled as predictors of mortality and func-
tional disability status included measures of participants'
sex, age, race, marital status, educational level, duration of
diabetes, CVD, and self-rated health. Age, education, and
duration of diabetes were continuous variables. The dura-
tion of diabetes was calculated based on self-reported year
of diagnosis and year of first follow-up. Race was classified
into two categories (white and nonwhite). Marital status
was recoded into married or not married, with the not
married classification including individuals who were
widowed, never married, and separated/divorced. Cardio-
vascular disease (CVD) status was comprised of people
who indicated that they had hypertension or that they had
experienced a heart attack or a stroke. Self-rated health
was recoded in two classifications (excellent or very good,
good to poor).
Statistical analyses
To account for the complex sampling design, SUDAAN
statistical software, version 9.0 [37] was used in all statis-
tical analyses [38]. Multivariate logistic regression models
[39] were fit using the MULTILOG procedure with the
GENLOGIT (generalized logit) option of SUDAAN after
verifying the assumption of multicollinearity [40]. The
multivariate logistic regression model was fit using the
MULTILOG procedure of SUDAAN. Adjusted odds ratios
(AOR) for each of the three levels of outcomes, mortality
and functional disability status, and cognitive functioning
relative to the disability free were provided along with
their corresponding 95% confidence intervals.
Results
Of the 9447 participants of the SOA II, 1183 died and 426
were missing in the 1st follow-up, resulting in 7838 first
follow-up participants. This sample of 7838 participants
consisted of 1178 people with diabetes that was further
reduced to 650 people with diabetes who completed the
cognitive tasks at first follow-up without mild to severe
cognitive impairment (n = 56); an additional 91 partici-
pants were excluded due to incomplete information for
covariates, diabetes status, and outcome variables. There
was no difference in age (p = 0.122), educational attain-
ment (p = 0.799), and length of time with diabetes (p =
0.290) between those who were excluded due to incom-
plete information and those who were included in the
sample. However, those who were excluded due to incom-
plete information compared to those who were included
in the sample had lower first follow-up cognitive func-
tioning (p = 0.003).
The analysis consisted of 559 older adults (232 males and
327 females) with diabetes and no evidence of mild to
severe cognitive functioning. A first follow-up, they were
on average 77.81 (SE = .17) years old and on average were
diagnosed with diabetes 14.43 (SE = .43) years prior. The
sample consisted of community-dwelling people who
were primarily Caucasian (n = 477, weighted percentage
88.79%, SE = 1.39). More than half were female (n = 327,
weighted percentage 58.00%, SE  = 2.13), who were
unmarried (n = 321, weighted percentage 56.28%, SE =
2.17), with more than 2 chronic condition (n  = 307,
weighted percentage 57.92%, SE = 2.02), with CVD (n =
399, weighted percentage 71.40%, SE = 2.14), who were
disability free at first follow-up (n = 266, weighted per-
centage 48.64%, SE = 2.18) and rated their health as excel-
lent or very good (n = 160, weighted percentage 28.14%,
SE = 2.03) or as fair or poor (n = 399, weighted percentage
71.86%, SE = 2.03).
People with diabetes who rated their health as at least very
good at first follow-up were more likely to be disability
free than those people who rated their health as good or
fair or poor (Table 1). People with diabetes who had more
than 2 chronic health conditions were more likely to have
died and to have become disabled, while those with fewer
chronic conditions were disability free. Those with diabe-
tes and CVD were more likely to have died or to have
become disabled than those without CVD. People with
diabetes without a functional disability tended to have
higher levels of educational attainment and cognitive
functioning than people who are dead or disabled. People
with diabetes without a functional disability tended to
have higher levels of educational attainment and cogni-
tive functioning than people who died or became disa-
bled. There was no relationship between death and
functional disability status and duration of diabetes.BMC Geriatrics 2006, 6:8 http://www.biomedcentral.com/1471-2318/6/8
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A series of multivariate logistic regression models predict-
ing the combined 2-year mortality and functional disabil-
ity status were calculated after controlling for the
covariates of participants' sex, age, race, marital status,
educational level, duration of diabetes, CVD, and self-
rated health. The multivariate logistic regression models
allowed for multiple outcomes of mortality and func-
tional disability to be compared simultaneously to the ref-
erence group of disability free. Persons with diabetes who
had the lowest levels of cognitive functioning relative to
the highest level of cognitive functioning had greater odds
of dying (AOR = 0.80, 95% CI = 0.67–0.96) or becoming
disabled (AOR = 0.87, 95% CI = 0.78–0.97). Furthermore,
for death and functional disability, a graded relationship
with cognitive functioning was apparent.
Discussion
In this longitudinal study of US adults with diabetes aged
≥ 70 years who were functioning cognitively in the normal
range, poor cognitive functioning was a significant and
independent predictor of subsequent mortality and the
development of functional disability. Persons with diabe-
tes and lower levels of cognitive functioning were more
likely to die or to become functionally disabled than those
with the higher levels of cognition. Interestingly, length of
diabetes was not related to mortality or functional disabil-
ity.
Consistent with previous research, which does not focus
on older adults with diabetes, we found that cognitive
functioning is a predictor of functional disability [3,15-
21]. Older adults with diabetes and low normal levels of
cognition were approximately 20% more likely to die and
13% more likely to become disabled than those with
higher levels of cognitive functioning over a 2-year period.
This finding is alarming since accelerated declines in cog-
nitive functioning have been consistently reported for
older and middle-aged adults with diabetes [1-9].
The accelerated cognitive aging associated with diabetes
suggests a more rapid aging of the central nervous system
compared to older adults without diabetes [27]. The per-
formance of people with diabetes on the TICS is equiva-
lent to aging 4 years [6]. There are several plausible
biological explanations of the relationship between dia-
betes and accelerated cognitive aging. Diabetes may inter-
act with normative aging processes by additionally
decreasing hippocampal volume resulting in cognitive
decrements beginning in the 60s, manifesting in mainly
memory-related changes [5]. Cerebro- and cardiovascular
disease also might explain the association between diabe-
tes and cognitive impairment because diabetes is a risk
factor for stroke and hypertension both of which are pre-
dictors of dementia [6]. Abnormal levels of blood glucose
at a cellular level could result in cerebro- and cardiovascu-
lar disease from failures to manage and monitor their dia-
betes properly [6].
Cognitive functioning has been identified as an important
factor related to adherence by older adults to antihyper-
tensive and arthritis treatment regimens [41] as well as
remembering medical information [42]. Declining cogni-
tive functioning in people with diabetes can have implica-
tions for adherence to treatment and to medication
regimens, [9] the latter an IADL task. Sinclair and col-
leagues [2] reported that people who had diabetes and
lower levels of cognitive functioning were less likely to be
involved in monitoring their diabetes and in their treat-
ment regimen, resulting in more hospitalizations, more
ADL limitations, and the need for more personal assist-
ance; thus, increased functional disability and mortality.
The relationship between cognitive functioning and
adherence to treatment appears bidirectional. To mini-
mize diabetes-related declines in cognitive functioning,
older adults with diabetes should monitor their diabetes
and adhere to treatment regimens [43]. It has been sug-
gested that, in comparison with people with diabetes who
do not adhere to their treatment regimen, cognitive
decline is less in people adhering to either a monotherapy
(use of sulfonylurea, metformin, or thiazolidinedione) or
combination (sulfonylurea with another glucose-lower-
ing agent, insulin, or metformin and insulin) [2,43], but
other research does not support this finding with people
who are using short-term glycemic control.[20]
Changes in performance on tasks of cognitive functioning
may quickly and efficiently demonstrate changes in neu-
ropsychological functioning and serve as a warning symp-
tom for hypoglycemia [6]. That also can be an early
indicator of future functional disability. The importance
of cognition on functional disability was noted by observ-
ing the abilities of older adults that allow them to live
independently, such as cognitive functioning, might be
more important in predicting functional disability, insti-
tutionalization, and subsequently death than their medi-
cal diagnoses [2]. This is especially of concern for older
adults with diabetes, considering the reported accelerated
rates of cognitive decline in this group versus those with-
out diabetes [1,44].
Our study demonstrates the potential of basic cognitive
screening measures, which could have implications for
health-care providers. Several brief measures to assess cog-
nitive functioning are available that have respectable psy-
chometric properties, such as the TICS, [27] Mini-Mental
State Exam, Modified Mini-Mental State Exam, and the
Short Portable Mental Status Questionnaire [45]. These
instruments could allow patients who might be at the
greatest risk of cognitive impairment, and subsequentBMC Geriatrics 2006, 6:8 http://www.biomedcentral.com/1471-2318/6/8
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death or functional disability to be identified and targeted
for interventions.
Practitioners should keep in mind that depression has
been shown to impair cognitive functioning, which is
important because the rates of depression are higher in
people with diabetes [8]. Bruce and colleagues [46]
reported that in their sample of people with diabetes who
were 70 years old and older, 14.2% were clinically
depressed, 50.2% reported one or more depressive symp-
toms, and only 36% were free of depressive symptoms.
Various cognitive interventions have been successful at
reversing age-related decrements in the cognitive compo-
nents of inductive reasoning and spatial ability over 7
years, [42] improving the IADL task of managing medica-
tions, [47] and improving short-term memory perform-
ance in patients with Alzheimer's disease [48]. A challenge
for planners and policy makers is to understand the heter-
ogeneity of the trajectory of functional disability, as some
persons steadily decline, resulting in their institutionaliza-
tion or death, while others experience fluctuations and
reversals of functional disability [12,36]. Understanding
Table 1: Weighted Percentages or Means (Standard Error) of Mortality and Functional Disability Status among US Adults with 
Diabetes Mellitus aged ≥ 70, Longitudinal Study of Aging II, 1997/1998–1999/2000.
Functional disability status at second follow-up*
Characteristics n Dead (n = 67) Disabled (n = 321) Non-Disabled (n = 171) p-value
Sex, % 0.06
Male 232 15.16 (2.30) 51.20 (3.15) 33.65 (3.17)
Female 327 11.24 (1.84) 60.60 (2.48) 28.15 (2.18)
Mean age at study entry, yrs 559 77.92 (0.51)a 78.18 (0.28)b 76.69 (0.27)a,b <0.01
Race or Ethnicity, % 0.40
White 477 12.79 (1.45) 55.90 (2.16) 31.31 (2.07)
Other 82 13.67 (5.03) 62.60 (6.89) 23.73 (5.02)
Marital status, % 0.18
Married 238 13.64 (2.26) 52.04 (3.49) 34.32 (3.15)
Unmarried 321 12.30 (1.92) 60.24 (2.54) 27.46 (2.41)
Mean cognitive functioning 559 13.00 (0.30)c 13.41 (0.12)d 14.42 (0.18)c,d <0.01
Mean educational attainment, yrs 559 10.75 (0.37)e 10.09 (0.20) f 12.19 (0.22) e,f <0.01
Mean duration of diabetes, yrs 559 13.48 (0.97) 14.50 (0.62) 13.77 (0.85) 0.62
# Chronic conditions, % <0.01
0–2 252 9.00 (1.92) 48.94 (3.47) 42.06 (3.52)
>2 307 16.08 (2.18) 62.99 (2.58) 20.94 (2.26)
CVD, % <0.01
Yes 399 14.22 (1.74) 61.22 (2.43) 24.57 (2.10)
No 160 9.57 (1.74) 45.25 (4.13) 45.17 (4.21)
Prior Disability Status, % <0.01
Disabled 293 14.98 (2.20) 72.56 (2.62) 12.45 (1.88)
Non-Disabled 266 10.68 (1.93) 39.86 (3.19) 49.47 (3.21)
Self-rated health, % <0.01
Excellent/very good 160 7.06 (2.06) 42.57 (3.69) 50.37 (3.87)
Good/fair/poor 399 15.17 (1.84) 62.17 (2.32) 22.67 (2.09)
TOTAL 559 12.89 (1.40) 56.65 (1.98) 30.46 (1.84)
Abbreviations: ADL, activities of daily living; IADL instrumental activities of daily living; NA not applicable.
Items with like subscripts are statistically significant from each other (p < 0.05).
* Weighted estimates.BMC Geriatrics 2006, 6:8 http://www.biomedcentral.com/1471-2318/6/8
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predictors of functional disability and how interventions
relate to its incidence might provide some insight.
Our study has several limitations. First, as in other studies
[19], functional disability outcomes were assessed using
respondent-reported ADL and IADL measures instead of
performance-based tasks. Although, performance-based
measures might be a desired method of assessment, they
may not reflect adaptations a person makes to successfully
complete a task, but respondent-reported ADL measures
can reduce the amount of missing data. Second, unfortu-
nately, medication adherence and depression were not
assessed on the LSOA II, which can potentially impair cog-
nition. Despite these limitations, our prospective study
contributes to the literature by emphasizing the impor-
tance of cognitive functioning in the development of
functional disability and mortality in a representative
population of older adults with diabetes who were free of
cognitive impairment.
Conclusion
Cognitive functioning among persons with diabetes is
predictive of death and the development of functional dis-
ability over a 2-year interval. Older adults with diabetes
and low normal levels of cognition, yet within normal
ranges, were approximately 20% more likely to die and
13% more likely to become disabled than those with
higher levels of cognitive functioning over a 2-year period.
Health-care providers should consider using brief cogni-
tive screening measures as indicators of mortality and dis-
ablement in their older patients with diabetes. This will
allow at-risk older adults with diabetes to be targeted for
interventions minimizing cognitive decline and func-
tional disability, as well as targeting interventions and
educational materials focusing on adherence to treatment
and diabetes monitoring to appropriate individuals.
These interventions potentially could minimize acceler-
ated cognitive aging associated with diabetes; thus, delay-
ing mortality and the development of functional
disability.
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